Cytodyn Inc (CYDY)

[JPG77]

Wrong - that didn't happen. As Dr. Laserai said during the Oct 20, 2020 investor's call - "So as Nader said, there was the DSMC meeting last Thursday and during the intro to the meeting, I had asked the members of the committee to look at the clinical signals, mortality signals and specifically to address a question of whether we needed to adjust the dosing. When we had submitted CD10 and CD12, we had proposed two doses for the Mild to Moderate patients, FOUR DOSES for the Severe and Critical and the FDA PUSHED BACK AND MADE US GIVE TWO DOSES for BOTH study populations. I’ve I’ve never actually been comfortable with that."

CYDY set it up as 2 doses and tried to get 4 doses half way through the trial